Filing Flows › Eastman Chemical (EMN) › Q3 2026 › vs Q3 2025
Eastman Chemical (EMN) Q3 2026 vs Q3 2025 (year over year)
Eastman Chemical's revenue rose $183M (+8%) from $2.2B in Q3 2025 to $2.4B in Q3 2026. Gross margin 22.3% against 19.7% (+2.6 pts).
Eastman Chemical, Q3 2026: revenue $2.4B (+8% year over year), operating margin 10.4%, net earnings $253M, operating cash flow $290M. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Gross margin | 22.3% | 19.7% | +2.6 pts |
| Operating margin | 10.4% | 6.1% | +4.4 pts |
| Net margin | 10.6% | 3.1% | +7.5 pts |
| Free cash flow margin | 8.2% | 12.0% | -3.9 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $2.4B | $2.2B | $183M | +8% |
| Gross profit | $532M | $433M | $99.0M | +23% |
| Cost of revenue | $1.9B | $1.8B | $84.0M | +5% |
| Operating profit | $249M | $134M | $115M | +86% |
| Operating expenses | $283M | $299M | −$16.0M | -5% |
| Pre-tax earnings | $249M | $134M | $115M | +86% |
| Research & development | $63.0M | $63.0M | $0 | 0% |
| SG&A | $171M | $160M | $11.0M | +7% |
| Other operating costs | $49.0M | $76.0M | −$27.0M | -36% |
| Income tax benefit | $4.0M | −$65.0M | $69.0M | — |
| Net earnings | $253M | $69.0M | $184M | +267% |
| Depreciation & amortization | $134M | $129M | $5.0M | +4% |
| Share-based compensation | $16.0M | $13.0M | $3.0M | +23% |
| Working capital & other | $113M | −$191M | $304M | — |
| Operating cash flow | $290M | $402M | −$112M | -28% |
| Free cash flow (OCF − capex) | $195M | $265M | −$70.0M | -26% |
| Capital expenditures | $95.0M | $137M | −$42.0M | -31% |
Questions
How much did Eastman Chemical's revenue grow year over year in Q3 2026?
Eastman Chemical's revenue rose $183M (+8%) from $2.2B in Q3 2025 to $2.4B in Q3 2026. Gross margin 22.3% against 19.7% (+2.6 pts).